Andrew Clair

1.1k total citations
35 papers, 698 citations indexed

About

Andrew Clair is a scholar working on Pharmacology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Andrew Clair has authored 35 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 23 papers in Psychiatry and Mental health and 12 papers in Cognitive Neuroscience. Recurrent topics in Andrew Clair's work include Fibromyalgia and Chronic Fatigue Syndrome Research (23 papers), Musculoskeletal pain and rehabilitation (22 papers) and Pain Management and Placebo Effect (9 papers). Andrew Clair is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (23 papers), Musculoskeletal pain and rehabilitation (22 papers) and Pain Management and Placebo Effect (9 papers). Andrew Clair collaborates with scholars based in United States, United Kingdom and France. Andrew Clair's co-authors include Birol Emir, Lesley M. Arnold, Andrew Thorpe, Don L. Goldenberg, Ed Whalen, Daniel J. Clauw, L. Pauer, Bruce Parsons, Charles P. Taylor and Raymond Cheung and has published in prestigious journals such as SHILAP Revista de lepidopterología, Trends in Pharmacological Sciences and Journal of Pharmaceutical Sciences.

In The Last Decade

Andrew Clair

34 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Clair United States 15 314 299 218 153 110 35 698
Emmanuel Bäckryd Sweden 18 352 1.1× 265 0.9× 403 1.8× 114 0.7× 123 1.1× 60 908
Michael A. Ueberall Germany 12 207 0.7× 134 0.4× 136 0.6× 84 0.5× 72 0.7× 28 588
L. Pauer United States 19 405 1.3× 402 1.3× 407 1.9× 252 1.6× 206 1.9× 39 1.1k
Liu Shui China 5 153 0.5× 207 0.7× 153 0.7× 109 0.7× 49 0.4× 8 669
Thomas Toelle Germany 12 151 0.5× 373 1.2× 434 2.0× 116 0.8× 210 1.9× 18 859
A. J. Clark Canada 14 125 0.4× 381 1.3× 244 1.1× 160 1.0× 68 0.6× 24 833
George Mensing United States 5 201 0.6× 369 1.2× 196 0.9× 195 1.3× 31 0.3× 16 847
Fujun Wang United States 10 288 0.9× 427 1.4× 459 2.1× 165 1.1× 257 2.3× 17 888
Rachael Mann United States 10 113 0.4× 266 0.9× 303 1.4× 67 0.4× 177 1.6× 13 599
Rebecca Baik United States 11 180 0.6× 243 0.8× 149 0.7× 57 0.4× 99 0.9× 17 588

Countries citing papers authored by Andrew Clair

Since Specialization
Citations

This map shows the geographic impact of Andrew Clair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Clair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Clair more than expected).

Fields of papers citing papers by Andrew Clair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Clair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Clair. The network helps show where Andrew Clair may publish in the future.

Co-authorship network of co-authors of Andrew Clair

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Clair. A scholar is included among the top collaborators of Andrew Clair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Clair. Andrew Clair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allman, Kimberly D, et al.. (2019). Therapy Management Using Modified 2-Weeks-On/1-Week-Off Dosing Schedule in Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario. Journal of the Advanced Practitioner in Oncology. 10(5). 483–493. 1 indexed citations
2.
Silverman, Stuart L., Miroslav Bačkonja, L. Pauer, et al.. (2017). Effect of Baseline Characteristics on the Pain Response to Pregabalin in Fibromyalgia Patients with Comorbid Depression. Pain Medicine. 19(3). 419–428. 7 indexed citations
3.
Mann, Rachael, Heather McElroy, Margarita Udall, et al.. (2016). Progression of fibromyalgia: results from a 2-year observational fibromyalgia and chronic pain study in the US. Journal of Pain Research. 9. 325–325. 12 indexed citations
4.
Arnold, Lesley M., Kenneth N. Schikler, Lucinda Bateman, et al.. (2016). Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study. Pediatric Rheumatology. 14(1). 46–46. 37 indexed citations
5.
Argoff, Charles E., et al.. (2016). Pregabalin Improves Pain Scores in Patients with Fibromyalgia Irrespective of Comorbid Osteoarthritis. Pain Medicine. 17(11). 2100–2108. 7 indexed citations
6.
Schaefer, Caroline, Edgar H. Adams, Margarita Udall, et al.. (2016). Fibromyalgia Outcomes Over Time: Results from a Prospective Observational Study in the United States. The Open Rheumatology Journal. 10(1). 109–121. 11 indexed citations
7.
Parsons, Bruce, Charles Argoff, Andrew Clair, & Birol Emir. (2016). Improvement in pain severity category in clinical trials of pregabalin. Journal of Pain Research. Volume 9. 779–785. 11 indexed citations
8.
Pérez, Concepción, et al.. (2016). Does Duration of Neuropathic Pain Impact the Effectiveness of Pregabalin?. Pain Practice. 17(4). 470–479. 11 indexed citations
9.
Golden, Angela, et al.. (2015). Living with fibromyalgia: results from the functioning with fibro survey highlight patients' experiences and relationships with health care providers. SHILAP Revista de lepidopterología. 3 indexed citations
10.
Clair, Andrew & Birol Emir. (2015). The safety and efficacy of pregabalin for treating subjects with fibromyalgia and moderate or severe baseline widespread pain. Current Medical Research and Opinion. 32(3). 601–610. 16 indexed citations
11.
Masters, Elizabeth T., Jack Mardekian, Birol Emir, et al.. (2015). Electronic medical record data to identify variables associated with a fibromyalgia diagnosis: importance of health care resource utilization. Journal of Pain Research. 8. 131–131. 10 indexed citations
12.
Arnold, Lesley M., Piercarlo Sarzi‐Puttini, Pierre Arsenault, et al.. (2015). Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Comorbid Depression Taking Concurrent Antidepressant Medication: A Randomized, Placebo-controlled Study. The Journal of Rheumatology. 42(7). 1237–1244. 35 indexed citations
13.
Fink, J. Stephen, Bruce Parsons, Birol Emir, & Andrew Clair. (2015). Temporal analysis of pain responders and common adverse events: when do these first appear following treatment with pregabalin. Journal of Pain Research. 8. 303–303. 13 indexed citations
14.
Arnold, Lesley M., Pierre Arsenault, Cynthia Huffman, et al.. (2014). Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study. Current Medical Research and Opinion. 30(10). 2069–2083. 23 indexed citations
15.
Arnold, Lesley M., Birol Emir, L. Pauer, Malca Resnick, & Andrew Clair. (2014). Time to Improvement of Pain and Sleep Quality in Clinical Trials of Pregabalin for the Treatment of Fibromyalgia. Pain Medicine. 16(1). 176–185. 20 indexed citations
16.
Stahl, Stephen M., Frank Porreca, Charles P. Taylor, et al.. (2013). The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities?. Trends in Pharmacological Sciences. 34(6). 332–339. 97 indexed citations
17.
Winkelman, John W., Alison W. Gagnon, & Andrew Clair. (2013). Sensory symptoms in restless legs syndrome: the enigma of pain. Sleep Medicine. 14(10). 934–942. 35 indexed citations
18.
Roth, Thomas, Lesley M. Arnold, Diego García‐Borreguero, Malca Resnick, & Andrew Clair. (2013). A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions. Sleep Medicine Reviews. 18(3). 261–271. 42 indexed citations
19.
Arnold, Lesley M., Joseph C. Cappelleri, Andrew Clair, & Elizabeth T. Masters. (2013). Interpreting Effect Sizes and Clinical Relevance of Pharmacological Interventions for Fibromyalgia. Pain and Therapy. 2(1). 65–71. 12 indexed citations
20.
Thorpe, Andrew, Andrew Clair, Shawn Hochman, & Stefan Clemens. (2011). Possible Sites of Therapeutic Action in Restless Legs Syndrome: Focus on Dopamine and α<sub>2</sub>δ Ligands. European Neurology. 66(1). 18–29. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026